HOLON, Israel, Feb. 8, 2017 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and developmentof first-in-class therapeutics for cancer immunotherapy, announced today that the Company will release its fourth quarter and full year 2017 financial results on Wednesday, February 21, 2018 before the U.S. financial markets
To access the live conference call by telephone, please dial 1-888-668-9141 from the U.S., or +972-3-918-0610 internationally. The call will also be available via live webcast through Compugen's website, located at the following link. Following the live audio webcast, a replay will be available on the Company's website.
About CompugenCompugen is a therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company's therapeutic pipeline consists of immuno-oncology programs against novel drug targets it has discovered, including T cell immune checkpoints and myeloid target programs. Compugen's business model is to selectively enter into collaborations for its novel targets and related drug product candidates at various stages of research and development. The Company is headquartered in Israel, with R&D facilities in both Israel and South San Francisco, CA. Compugen's shares are listed on NASDAQ and the Tel Aviv Stock Exchange under the ticker symbol CGEN. For additional information, please visit Compugen's corporate website at http://www.cgen.com.
Company contact:Elana HolzmanDirector, Investor Relations and Corporate CommunicationsCompugen Ltd.Email: firstname.lastname@example.orgTel: +972 (3) 765-8124
Investor Relations contact:Burns McClellan, Inc.Jill SteierEmail: email@example.com Tel: +1-212-213-0006
View original content:http://www.prnewswire.com/news-releases/compugen-fourth-quarter-and-full-year-2017-conference-call-scheduled-for-wednesday-february-21-2018-at-1000-am-et-300595696.html
SOURCE Compugen Ltd.
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All